Browsing by Subject Clopidogrel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 8 to 15 of 15 < previous 
Issue DateTitleAuthor(s)
2015-06Pharmacist-led CYP2C19 genotyping in patients on clopidogrel therapy following percutaneous coronary interventionWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2016-03Pharmacist-led rapid point-of-care CYP2C19 genotyping for individualisation of antiplatelet therapyWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.
2015Pharmacogenetic implications in clopidogrel therapy : a pharmacist-Ied management approachWirth, Francesca
2015-10Point-of-care CYP2C19 genotyping in patients prescribed clopidogrel therapy following a percutaneous coronary interventionWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.
2015-09Prevalence of the CYP2C19 *2 allele in Maltese patients on clopidogrel therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2005Randomized clinical trial of the antiplatelet effects of aspirin–clopidogrel combination versus aspirin alone after lower limb angioplastyCassar, Kevin; Ford, Isabel; Greaves, Mike; Bachoo, Paul; Brittenden, Julie
2017-01Rapid point-of-care CYP2C19*2 genotyping to personalise antiplatelet therapy in patients undergoing coronary stentingWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.
2006Variability in responsiveness to clopidogrel in patients with intermittent claudicationCassar, Kevin; Bachoo, Paul; Ford, Isobel; Greaves, Michael; Brittenden, Julie